↓ Skip to main content

Dove Medical Press

Article Metrics

Prophylactic onabotulinumtoxinA in patients with chronic migraine and comorbid depression: An open-label, multicenter, pilot study of efficacy, safety and effect on headache-related disability…

Overview of attention for article published in International Journal of General Medicine, January 2015
Altmetric Badge

Mentioned by

twitter
1 tweeter

Citations

dimensions_citation
33 Dimensions

Readers on

mendeley
35 Mendeley
Title
Prophylactic onabotulinumtoxinA in patients with chronic migraine and comorbid depression: An open-label, multicenter, pilot study of efficacy, safety and effect on headache-related disability, depression, and anxiety.
Published in
International Journal of General Medicine, January 2015
DOI 10.2147/ijgm.s70456
Pubmed ID
Authors

Guy P Boudreau, Brian M Grosberg, Peter J McAllister, Richard B Lipton, Dawn C Buse

Abstract

Chronic migraine is associated with significant headache-related disability and psychiatric comorbidity. OnabotulinumtoxinA (BOTOX(®)) is effective and well tolerated in the prophylactic treatment of chronic migraine. This study aimed to provide preliminary data on the efficacy and safety of prophylactic onabotulinumtoxinA in patients with chronic migraine and comorbid depressive symptoms.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 35 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 3%
Unknown 34 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 8 23%
Student > Doctoral Student 7 20%
Student > Master 5 14%
Student > Bachelor 4 11%
Student > Ph. D. Student 4 11%
Other 5 14%
Unknown 2 6%
Readers by discipline Count As %
Medicine and Dentistry 23 66%
Nursing and Health Professions 2 6%
Neuroscience 2 6%
Social Sciences 2 6%
Immunology and Microbiology 1 3%
Other 2 6%
Unknown 3 9%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 March 2015.
All research outputs
#4,046,032
of 4,833,580 outputs
Outputs from International Journal of General Medicine
#206
of 278 outputs
Outputs of similar age
#119,609
of 144,117 outputs
Outputs of similar age from International Journal of General Medicine
#3
of 7 outputs
Altmetric has tracked 4,833,580 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 278 research outputs from this source. They receive a mean Attention Score of 3.4. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 144,117 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 7 others from the same source and published within six weeks on either side of this one. This one has scored higher than 4 of them.